Sildenafil Completed Phase 4 Trials for Pulmonary Arterial Hypertension (PAH) Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02891850Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapy
NCT00323297Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension
NCT00433329Combination Therapy in Pulmonary Arterial Hypertension
NCT00617305Study of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor (PDE5i) Therapy in Pulmonary Arterial Hypertension (ATHENA-1)